Complete TRVI Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
TRVI Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 9 peer companies in Healthcare
P/E Ratio
$-25.17
-538.8%
Peer Median: 62.5x
EV/EBITDA
$0.00
-100.0%
Peer Median: 45.6x
P/S Ratio
$0.00
-100.0%
Peer Median: 7.5x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for TRVI's business model and current situation.
Multiple Comparison
| Multiple | TRVI Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -14.2x | 62.5x | 62.5x | -122.8% | Undervalued |
| EV/EBITDA | Infinityx | 45.6x | 45.6x | Infinity% | Overvalued |
| P/S Ratio | Infinityx | 7.5x | 7.0x | Infinity% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $1.18B | 0.0x | 0.0x | 0.0x | |
| $0.74B | 0.0x | 0.0x | 3.3x | |
| $0.68B | 0.0x | 0.0x | 62.0x | |
| $0.60B | 0.0x | 0.0x | 2.2x | |
| $0.68B | 0.0x | 0.0x | 0.0x | |
| $0.51B | 0.0x | 0.0x | 0.0x | |
| $0.36B | 0.0x | 0.0x | 7.5x | |
| $0.49B | 0.0x | 0.0x | 195.9x | |
| $730.57B | 62.5x | 45.6x | 14.9x |